Oprah has endured as a weight-loss icon. Not even GLP-1s can change that.

Oprah Winfrey has massively influenced wellness and diet culture for decades, now taking the spotlight to share her experience with GLP-1s. Don Arnold/Getty Images Oprah Winfrey has long been an influential figure in the health and wellness industry. Her recent comments about GLP-1s mark a turning point in how we think about losing weight. Experts […]
Novo’s Wegovy Pill Looks A Lot Like Zepbound — In One Week – Investor’s Business Daily

Novo’s Wegovy Pill Looks A Lot Like Zepbound — In One Week Investor’s Business Daily Novo Nordisk shares rise 8% after Wegovy obesity pill has ‘solid’ launch CNBC Lubbock Doctor compares weight loss injections to new pills KCBD Novo Nordisk Stock Jumps. The Wegovy Pill Is Back in Focus Yahoo Finance Novo Nordisk sees pills capturing over third of […]
Novo’s Wegovy pill tracks 3,071 prescriptions in first days of launch – Reuters

Novo’s Wegovy pill tracks 3,071 prescriptions in first days of launch Reuters Novo Nordisk shares rise 8% after Wegovy obesity pill has ‘solid’ launch CNBC Lubbock Doctor compares weight loss injections to new pills KCBD Novo Nordisk Stock Jumps. The Wegovy Pill Is Back in Focus Yahoo Finance Novo Nordisk sees pills capturing over third of GLP-1 obesity market […]
‘Bar Rescue’ host Jon Taffer on new restaurant reality: Smaller portions, lighter appetites and higher costs

America’s restaurant industry is quietly reworking its playbook as weight-loss drugs change how people eat, how much food they leave behind and what they are willing to pay. “Bar Rescue” host Jon Taffer joined FOX Business’ Stuart Varney on “Varney & Co.” to explain how the rise of weight-loss drugs is changing consumer behavior. Taffer […]
Incretin Based Therapy in Heart Failure with Preserved Ejection Fraction

Join the American Heart Association for an insightful session with Dr. Clyde Yancy and Dr. Dhruv Kazi. Recent clinical trials demonstrate the efficacy of incretin-based therapies (including GLP1-RA) in the care of HFpEF patients and their pivotal role in improving patient quality of life. Dr. Clyde Yancy discusses the latest evidence from these landmark trials […]
Arthur Brooks: Do GLP-1s Make Us Happy?

In my column last Monday, I wrote about how to make better New Year’s resolutions—ones that are less likely to flop, but that are also challenging enough to provide satisfaction. Why? Because accomplishing something with a degree of struggle is the way to realize joy. I gave the example of using GLP-1 drugs for weight […]
Wegovy pill off to a fast start; Ex-Emergent CEO sued for insider trading

More than 3,000 prescriptions were written for Novo’s GLP-1 pill in its first week on the market. Elsewhere, Emergent reached a settlement over a trading scandal and Sanofi is reportedly circling an eye drug biotech.
‘Another self own’: Trump comment sparks internet rumors of president on Ozempic

President Donald Trump touted Friday his new health care plan, which he dubbed “The Great Health Care Plan” during a press conference from the White House, but his meandering remarks about a “friend” who took the weight-loss drug Ozempic quickly fueled online speculation about whether the president himself was using it. “A friend of mine […]
‘Shamed’ Oprah Winfrey ‘Blamed Herself’ for Packing on the Pounds Before Using Weight Loss Medications to Shed 50Lbs — And Now She Can’t Quit the Jabs

Oprah dropped about 50 pounds after going on GLP-1 drugs two and a half years ago, but then quickly gained back 20 pounds when she stopped taking them.
Signaling architecture of the glucagon-like peptide-1 receptor

The glucagon-like peptide-1 receptor (GLP-1R) is a class B1 G protein–coupled receptor and major therapeutic target in type 2 diabetes and obesity. Beyond its canonical role in Gαs/cAMP signaling, GLP-1R is increasingly recognized as an organizer of spatiotemporally defined signaling nanodomains, or “signalosomes.” This Review highlights our current knowledge on the mechanisms of assembly and […]